Quantcast

Latest Amgen Stories

2014-11-19 23:00:57

ResearchMoz.us include new market research report " China Recombinant Protein Drug Industry, 2014-2017: Market Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection

2014-11-19 12:25:57

Surveyed European Oncologists Expect to Use Future Biosimilar G-CSFs in a Greater Proportion of Eligible Patients than Biosimilar MAbs, According to Findings from Decision Resources Group BURLINGTON,

2014-11-18 16:26:22

Additional Data Analysis Showed Every Two Week and Monthly Dosing Regimens of Evolocumab Were Clinically Equivalent THOUSAND OAKS, Calif., Nov.

2014-11-14 16:25:04

THOUSAND OAKS, Calif., Nov. 14, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will participate at the Jefferies Global Healthcare Conference on Wednesday, Nov.

2014-11-12 23:00:57

RnRMarketResearch.com adds "Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2014" to its store.

2014-11-12 16:28:54

Thirteen Presentations Include New Analyses of PCSK9 Inhibitor at Upcoming American Heart Association Scientific Sessions THOUSAND OAKS, Calif., Nov.

2014-11-12 08:34:23

Foundation's Commitment to Science, Technology, Engineering and Math (STEM) Education Surpasses $100 Million Milestone THOUSAND OAKS, Calif., Nov.

2014-11-11 16:25:45

Brodalumab Meets All Primary and All Key Secondary Endpoints THOUSAND OAKS, Calif. and LONDON, Nov.

2014-11-10 23:06:35

Mnemosyne appoints Vanessa King, Ph.D. Chief Executive Officer. Dr.